$14.37
0[0.00%]
Last update: 4:00PM Get Real Time Here
UroGen Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of UroGen Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | URGN | Q1 | -$1.30 | -$0.87 | — | — | $17.19M | $21.39M | — | — | Get Alert |
03/14/2024 | AM | URGN | Q4 | -$1.22 | -$0.68 | -$0.72 | -5.88% | $18.09M | $22.57M | $23.53M | 4.25% | Get Alert |
11/14/2023 | AM | URGN | Q3 | -$1.13 | -$0.85 | -$0.68 | 20.00% | $16.10M | $20.03M | $20.85M | 4.10% | Get Alert |
08/10/2023 | AM | URGN | Q2 | -$1.18 | -$1.14 | -$1.03 | 9.65% | $16.60M | $20.12M | $21.14M | 5.06% | Get Alert |
05/11/2023 | AM | URGN | Q1 | -$1.25 | -$1.33 | -$1.30 | 2.26% | $13.56M | $17.18M | $17.19M | 0.07% | Get Alert |
03/16/2023 | AM | URGN | Q4 | -$1.27 | -$1.07 | -$1.22 | -14.02% | $16.17M | $18.51M | $18.09M | -2.26% | Get Alert |
11/10/2022 | AM | URGN | Q3 | -$1.35 | -$1.16 | -$1.13 | 2.59% | $11.35M | $20.15M | $16.10M | -20.11% | Get Alert |
08/11/2022 | AM | URGN | Q2 | -$1.17 | -$1.23 | -$1.18 | 4.07% | $13.03M | $17.23M | $16.60M | -3.63% | Get Alert |
05/10/2022 | AM | URGN | Q1 | -$1.17 | -$1.33 | -$1.25 | 6.02% | $7.49M | $15.18M | $13.56M | -10.65% | Get Alert |
03/21/2022 | AM | URGN | Q4 | -$1.38 | -$1.17 | -$1.27 | -8.55% | $7.97M | $16.49M | $16.17M | -1.92% | Get Alert |
11/15/2021 | AM | URGN | Q3 | -$1.31 | -$1.29 | -$1.35 | -4.65% | $3.46M | $15.42M | $11.35M | -26.39% | Get Alert |
08/04/2021 | AM | URGN | Q2 | -$1.44 | -$1.27 | -$1.17 | 7.87% | $372.00K | $10.21M | $13.03M | 27.64% | Get Alert |
05/13/2021 | AM | URGN | Q1 | -$1.79 | -$1.29 | -$1.17 | 9.30% | $0.00 | $9.05M | $7.49M | -17.29% | Get Alert |
03/18/2021 | AM | URGN | Q4 | -$1.86 | -$1.37 | -$1.38 | -0.73% | $0.00 | $7.57M | $7.97M | 5.23% | Get Alert |
11/09/2020 | AM | URGN | Q3 | -$1.06 | -$1.49 | -$1.31 | 12.08% | $0.00 | $3.34M | $3.46M | 3.62% | Get Alert |
08/10/2020 | AM | URGN | Q2 | -$1.08 | -$1.58 | -$1.44 | 8.86% | $18.00K | $260.00K | $372.00K | 43.08% | Get Alert |
05/07/2020 | AM | URGN | Q1 | -$1.11 | -$1.62 | -$1.79 | -10.49% | $0.00 | — | $0.00 | — | Get Alert |
03/02/2020 | AM | URGN | Q4 | -$1.46 | -$1.70 | -$1.86 | -9.41% | $0.00 | $117.85M | $0.00 | -100.00% | Get Alert |
11/12/2019 | AM | URGN | Q3 | -$1.28 | — | -$1.06 | — | $283.00K | — | $0.00 | — | Get Alert |
UroGen Pharma (URGN) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 14, 2024 for Q4.
The Actual EPS was $-0.72, which missed the estimate of $-0.68.
The Actual Revenue was $23.5M, which beat the estimate of $22.6M.
Browse earnings estimates, EPS, and revenue on all stocks.